Bal Pharma Limited — Results, 14-02-2025: Integrated Filing- Financial

Bal Pharma Limited has announced a board meeting to discuss the financial results for the quarter and nine months ended 31 December 2024. The company reported a revenue of ₹720.85 crore and a total income of ₹737.05 crore for the quarter. Profit before tax stood at ₹12.04 crore. The statutory auditors provided an unmodified opinion on these results, indicating solid governance practices. This news could foster a positive outlook among investors, reflecting efficient management and potential growth prospects despite market uncertainties.